James Gourzis, M.D., Ph.D.

James Gourzis, M.D., Ph.D. has more than 30 years of experience in designing and leading clinical trials, implementing regulatory strategies and negotiating licensing transactions. Dr. Gourzis currently provides consulting services to a wide range of biotechnology and medical device companies with respect to scientific, strategic and regulatory considerations associated with drug and biologic development.

Before his role as a consultant, Dr. Gourzis was an executive with PAREXEL International Corp., a contract research organization that provides a range of services to pharmaceutical and biotechnology companies throughout the entire product life cycle.

Dr. Gourzis began his career in the clinical research groups of McNeil Laboratories, Inc. and Schering Corp. He has experience in a broad range of therapeutic areas, including cardiology, immunology and infectious disease.

Dr. Gourzis received his bachelor’s degree in biology from Harvard University, his master’s degree in pharmacology from Boston University, and his M.D. from the University of Manitoba, Winnipeg, Canada. Dr. Gourzis also received a doctorate in pharmacology from the University of Manitoba.